Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, OGT Expand Partnership to Include Oligonucleotide Microarrays, SureSelect Products





NEW YORK (GenomeWeb News) – Agilent Technologies and Oxford Gene Technology today announced an expansion of an existing agreement for the provision of oligonucleotide microarrays and SureSelect target enrichment products to OGT for next-generation sequencing.

The deal builds on a partnership between the two firms dating back to 2007 when Agilent provided OGT access to its microarray platform. The agreement also made Agilent the OEM supplier of OGT-designed microarrays and made OGT an Agilent certified service provider.

Last year, OGT was the first company to achieve Agilent High-Throughput Microarray Certified Service Provider.

Terms of the extension were not disclosed.

Agilent's SureSelect Target Enrichment System is an in-solution hybridization capture technology that was originally developed in collaboration with the Broad Institute.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.